{"log_id": 1333357704792114843, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 6e-06, "average": 0.998241, "min": 0.991579}, "location": {"width": 441, "top": 129, "height": 43, "left": 187}, "words": "补充申请:按局24号令修改说明书、标签"}, {"probability": {"variance": 0, "average": 0.999183, "min": 0.998219}, "location": {"width": 193, "top": 135, "height": 44, "left": 904}, "words": "资料编号:3"}, {"probability": {"variance": 0.006751, "average": 0.97807, "min": 0.492792}, "location": {"width": 898, "top": 177, "height": 70, "left": 189}, "words": "一下列一些或一类药物已知或有可能是通过肝细胞色素P4503A(CYP3A)同功酶代谢途"}, {"probability": {"variance": 0.000564, "average": 0.989533, "min": 0.883139}, "location": {"width": 910, "top": 242, "height": 50, "left": 189}, "words": "径:阿普唑仑、阿司咪唑、卡马西平、西洛他唑、西沙必利、环孢菌素、丙吡胺、麦角生"}, {"probability": {"variance": 9.3e-05, "average": 0.994009, "min": 0.95968}, "location": {"width": 886, "top": 290, "height": 50, "left": 188}, "words": "物碱、洛伐他汀、甲泼尼龙、咪达唑仑、奥美拉唑、口服抗凝药(如华法林)、匹莫齐"}, {"probability": {"variance": 0.002564, "average": 0.987744, "min": 0.692505}, "location": {"width": 890, "top": 337, "height": 53, "left": 185}, "words": "特、奎尼丁、利发布丁、西地那非、辛伐他汀、他克莫司、特非那丁、三唑仑和长春碱"}, {"probability": {"variance": 1.1e-05, "average": 0.997655, "min": 0.985226}, "location": {"width": 901, "top": 386, "height": 52, "left": 185}, "words": "通过细胞色素P450系统中其它同功酶代谢的、机制相似的药物还有苯妥因、茶碱及丙基"}, {"probability": {"variance": 0.000122, "average": 0.993433, "min": 0.971858}, "location": {"width": 190, "top": 437, "height": 35, "left": 184}, "words": "戊酸钠类抗癫痫药"}, {"probability": {"variance": 1.9e-05, "average": 0.997296, "min": 0.980469}, "location": {"width": 866, "top": 484, "height": 52, "left": 229}, "words": "临床研究表明,当茶碱或卡马西平与克拉霉素合用时,其在循环系统的浓度轻度升高"}, {"probability": {"variance": 0.00063, "average": 0.992093, "min": 0.840719}, "location": {"width": 854, "top": 533, "height": 48, "left": 183}, "words": "但有统计学意义(p≤0.05)。当克拉霉素与奎尼丁、丙吡胺合用时应监测血药浓度"}, {"probability": {"variance": 0.013589, "average": 0.950308, "min": 0.522745}, "location": {"width": 866, "top": 576, "height": 56, "left": 226}, "words": "克拉霉素与HMG-CoA还原酶抑制剂(如洛伐他汀和辛伐他汀)合用时,极少有横纹肌"}, {"probability": {"variance": 1e-06, "average": 0.999229, "min": 0.997598}, "location": {"width": 120, "top": 627, "height": 29, "left": 179}, "words": "溶解的报道"}, {"probability": {"variance": 0.050433, "average": 0.708341, "min": 0.483768}, "location": {"width": 61, "top": 632, "height": 28, "left": 768}, "words": "/解"}, {"probability": {"variance": 0.00247, "average": 0.987856, "min": 0.693421}, "location": {"width": 862, "top": 672, "height": 54, "left": 225}, "words": "西沙必利与克拉霉素合用会使病人血液中西沙必利浓度升高,导致QT间期延长,心"}, {"probability": {"variance": 0.002706, "average": 0.98657, "min": 0.673589}, "location": {"width": 892, "top": 720, "height": 52, "left": 174}, "words": "律失常如室性心动过速、室颤和尖端扭转性室速。克拉霉素与匹莫齐特合用也会有此作"}, {"probability": {"variance": 0, "average": 0.999845, "min": 0.999845}, "location": {"width": 29, "top": 771, "height": 28, "left": 175}, "words": "用"}, {"probability": {"variance": 8e-06, "average": 0.99798, "min": 0.985461}, "location": {"width": 863, "top": 817, "height": 51, "left": 224}, "words": "大环内酯类药物能改变特非那丁的代谢而升高其血浓度,导致心律失常如室性心动过"}, {"probability": {"variance": 0.000233, "average": 0.994817, "min": 0.904032}, "location": {"width": 902, "top": 863, "height": 53, "left": 173}, "words": "速、室颤和尖端扭转性室速。对14名健康受试者的研究发现,克拉霉素与特非那丁合用"}, {"probability": {"variance": 0.002939, "average": 0.987554, "min": 0.658294}, "location": {"width": 898, "top": 910, "height": 53, "left": 175}, "words": "会引起特非那丁的酸性代谢物血浓度升高2~3倍,导致QT间期延长,但无任何临床症"}, {"probability": {"variance": 1.5e-05, "average": 0.996485, "min": 0.985504}, "location": {"width": 475, "top": 956, "height": 45, "left": 170}, "words": "状。克拉霉素与阿司咪唑合用也会有此作用。"}, {"probability": {"variance": 0.000282, "average": 0.9845, "min": 0.957905}, "location": {"width": 212, "top": 1009, "height": 30, "left": 174}, "words": "麦角胺和氢化麦角胺"}, {"probability": {"variance": 6.9e-05, "average": 0.995082, "min": 0.953994}, "location": {"width": 869, "top": 1054, "height": 54, "left": 216}, "words": "有报告显示,克拉霉素与麦角胺或氢化麦角胺同量给药可能会诱发急性麦角症,具体"}, {"probability": {"variance": 2.6e-05, "average": 0.997223, "min": 0.976323}, "location": {"width": 659, "top": 1104, "height": 44, "left": 169}, "words": "症状为血管痉挛、四肢及包括中枢神经系统在内的组织局部缺血"}, {"probability": {"variance": 8.9e-05, "average": 0.995411, "min": 0.967589}, "location": {"width": 237, "top": 1152, "height": 34, "left": 171}, "words": "与其它药物的相互作用"}, {"probability": {"variance": 5.8e-05, "average": 0.996637, "min": 0.962611}, "location": {"width": 775, "top": 1199, "height": 49, "left": 216}, "words": "克拉霉素与地高辛合用会引起地高辛血药浓度升高,故应进行血药浓度监测"}, {"probability": {"variance": 1.4e-05, "average": 0.996048, "min": 0.989553}, "location": {"width": 332, "top": 1245, "height": 38, "left": 170}, "words": "与抗逆转录病毒药物的相互作用"}, {"probability": {"variance": 0.013267, "average": 0.946965, "min": 0.52295}, "location": {"width": 838, "top": 1293, "height": 53, "left": 214}, "words": "HIV感染的成年人同时口服克拉莓素与齐多夫定会引起齐多夫定稳态血药浓度下降"}, {"probability": {"variance": 0.019804, "average": 0.941232, "min": 0.430222}, "location": {"width": 820, "top": 1339, "height": 50, "left": 164}, "words": "这主要是由于克拉霉素会干扰齐多夫定的吸收,故开服用时间可武下PHA"}, {"probability": {"variance": 0, "average": 0.460449, "min": 0.460449}, "location": {"width": 24, "top": 1368, "height": 24, "left": 1035}, "words": " i"}, {"probability": {"variance": 0.021732, "average": 0.9372, "min": 0.38575}, "location": {"width": 742, "top": 1388, "height": 52, "left": 167}, "words": "感染的儿科病人同时服用克拉霉素干混悬剂和齐多夫定或脱氧"}, {"probability": {"variance": 1.9e-05, "average": 0.996952, "min": 0.984661}, "location": {"width": 241, "top": 1439, "height": 36, "left": 165}, "words": "时未出现上述相互影响"}, {"probability": {"variance": 0.000336, "average": 0.994631, "min": 0.898215}, "location": {"width": 621, "top": 1488, "height": 42, "left": 213}, "words": "药动学研究表明,利托那韦(200mg,每天三次)和克拉霉素"}, {"probability": {"variance": 0.002683, "average": 0.962819, "min": 0.889564}, "location": {"width": 139, "top": 1503, "height": 33, "left": 937}, "words": "每天合"}, {"probability": {"variance": 0.004919, "average": 0.972533, "min": 0.60388}, "location": {"width": 776, "top": 1529, "height": 58, "left": 164}, "words": "用,克拉霉素代谢会明显被抑制,克拉霉素的Cmax、Cmin和AUC分别增"}, {"probability": {"variance": 1e-06, "average": 0.999252, "min": 0.997982}, "location": {"width": 57, "top": 1559, "height": 23, "left": 1009}, "words": "82%和"}, {"probability": {"variance": 0.015055, "average": 0.955252, "min": 0.448949}, "location": {"width": 908, "top": 1580, "height": 55, "left": 172}, "words": "7%,14-[R]-0H克拉素的生成受到明显抑制。由于克拉零素治疗窗较大,当病人肾功能"}], "language": -1}